InsidersTradesSigma
Follow the 아이엠바이오로직스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 아이엠바이오로직스 has logged 8 public disclosures. Market capitalisation: €258.3bn. The latest transaction was reported on 30 March 2026 (Purchase). Among the most active insiders: 아이엠엠인베스트먼트. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
아이엠바이오로직스 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative biological solutions.